Cynapsus Thera Cm Sh (CYNA)
40.48 +0.01 (+0.02%) 10/20/16 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Thu, Oct 20th, 2016
Results
download Want to compare other data? Select Fields| Symbol | CYNA | ORGO | SVRA | ||
| Company | Cynapsus Thera Cm Sh | Organogenesis Holdings Inc | Savara Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 40.48 | 3.74 | 2.63 | ||
| High | 40.49 | 4.28 | 2.93 | ||
| Low | 40.47 | 3.57 | 2.60 | ||
| Last | 40.48 | 4.26 | 2.92 | ||
| Change | +0.01 | +0.51 | +0.28 | ||
| % Change | +0.02% | +13.60% | +10.61% | ||
| Volume | 388,800 | 3,996,100 | 594,500 | ||
| 20-Day Average Volume | 139,670 | 1,381,935 | 1,381,785 | ||
| Previous Close | 40.47 | 3.75 | 2.64 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 40.34 | 4.49 | 2.81 | ||
| 20-Day Raw Stochastic | 84.80% | 36.10% | 80.00% | ||
| 20-Day Relative Strength | 90.93% | 49.25% | 53.83% | ||
| Weighted Alpha | +77.10 | -16.68 | -35.76 | ||
| Today's Opinion | N/A | 56% Buy | 48% Sell | ||
| Previous Opinion | N/A | 40% Buy | 80% Sell | ||
| Last Month's Opinion | N/A | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.07% since 10/13/16 | +10.08% since 04/04/25 | +2.46% since 04/04/25 | ||
| Low | 40.44 on 10/14/16 | 3.52 on 04/07/25 | 2.52 on 04/09/25 | ||
| High | 40.50 on 10/18/16 | 4.28 on 04/11/25 | 2.93 on 04/11/25 | ||
| 1-Month | |||||
| %Chg | +0.70% since 09/20/16 | -19.62% since 03/11/25 | +14.51% since 03/11/25 | ||
| Low | 39.42 on 09/23/16 | 3.52 on 04/07/25 | 2.50 on 03/12/25 | ||
| High | 40.67 on 10/10/16 | 5.57 on 03/25/25 | 3.02 on 04/02/25 | ||
| 3-Month | |||||
| %Chg | +155.23% since 07/20/16 | +41.53% since 01/10/25 | +5.04% since 01/10/25 | ||
| Low | 15.83 on 07/21/16 | 2.88 on 01/14/25 | 2.26 on 03/04/25 | ||
| High | 40.67 on 10/10/16 | 6.71 on 03/03/25 | 3.13 on 01/16/25 | ||
| 6-Month | |||||
| %Chg | +190.39% since 04/20/16 | +38.76% since 10/11/24 | -22.55% since 10/11/24 | ||
| Low | 11.17 on 05/09/16 | 2.75 on 11/04/24 | 2.26 on 03/04/25 | ||
| High | 40.67 on 10/10/16 | 6.71 on 03/03/25 | 4.30 on 11/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 532,220 | 540,287 | 504,088 | ||
| Shares Outstanding, K | 13,150 | 126,828 | 172,633 | ||
| Annual Sales | 0 | 482,040,000 | 0 | ||
| Annual Net Income | -21,530,000 | 860,000 | -95,880,000 | ||
| Last Quarter Sales | N/A | 126,660,000 | 0 | ||
| Last Quarter Net Income | N/A | 7,670,000 | -29,040,000 | ||
| 60-Month Beta | 0.49 | 1.79 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.04 on 02/27/25 | -0.13 on 03/27/25 | ||
| Latest Earnings Date | 11/10/16 | 05/08/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||